#pharmaceutical botany

• Abelia - A genus of ornamental flowering shrubs in the family Caprifoliaceae, native to East Asia and Mexico. In pharmaceutical botany, toxicology, and neuropsychiatry, extracts from Abelia species are studied for their content of biologically active secondary metabolites (iridoid glucosides, polyphenols). These compounds display antioxidant and neuroprotective therapeutic potential, being clinically investigated in experimental models to reduce oxidative stress in neurodegenerative diseases or alleviate neurosomatic anxiety symptoms.
• Abelia chinensis - The type species of the Abelia genus, native to China, characterized by dense and fragrant inflorescences. In medical biochemistry and phytotherapy, the species is intensely researched for isolating rare bioactive metabolites, such as iridoid glycosides and natural phenolic acids. These compounds are of significant interest in neuroprotection due to their experimentally proven capacity to mitigate neuronal cell degradation caused by free radicals, studied as adjuvants in countering oxidative stress within degenerative or cognitive pathologies.
• Abelia engleriana - A shrub species belonging to the Abelia genus, remarkable for its characteristic funnel-shaped flowers and high biological adaptability. In experimental phytotherapy, pharmacognosy, and toxicology, the species is monitored for its chemical profile rich in flavonoids and terpenic compounds. These metabolites are clinically studied in laboratory models to evaluate analgesic and peripheral anti-inflammatory effects, as well as the capacity to reduce stress-induced painful somatizations at the neuro-muscular level.
• Abelia floribunda - An evergreen shrub species native to Mexico, remarkable for its reddish-pink tubular flowers and abundant blooming. In medical biochemistry and pharmacognosy, extracts obtained from the leaves and flowers of Abelia floribunda are studied to identify specific triterpenes and phenolic acids. These bioactive compounds are investigated in laboratory models to evaluate their antimicrobial and anti-inflammatory properties, as well as their potential to reduce cellular oxidative stress biomarkers within the peripheral nervous system.
• Abelia triflora - A large shrub species native to the Himalayan mountain region, characterized by flowers often arranged in clusters of three and an intense fragrance. In experimental phytotherapy and phytochemical research, Abelia triflora is recognized for its content of secoiridoid glycosides and complex phenolic derivatives. These natural constituents are clinically studied in experimental neuroprotection models for their potential to reduce neuroinflammation and stabilize cellular metabolic homeostasis in the brain.
• Abelia uniflora - A shrub species belonging to the Abelia genus, native to China, characterized by solitary flowers borne on unique peduncles. In clinical biochemistry and pharmacognosy, extracts from Abelia uniflora are studied for isolating biologically active secondary metabolites, specifically cyclic monoterpenes and organic acids. These natural constituents exhibit neuroprotective and antioxidant potential, being experimentally researched in laboratory models to protect neuronal cell membranes against lipid peroxidation-induced degeneration.
• Abeliophyllum - A monotypic botanical genus in the family Oleaceae, represented exclusively by the species Abeliophyllum distichum (Korean white forsythia). In pharmaceutical botany, phyto-neurosciences, and toxicology, extracts from the aerial organs of this plant are intensively studied for their high concentration of phenylethanoid glycosides, flavonoids, and verbascoside compounds. These secondary metabolites display potent antioxidant, anti-inflammatory, and neuroprotective properties, being investigated in vitro and in vivo for their ability to mitigate neuroinflammation, inhibit acetylcholinesterase, and protect neuronal cells against oxidative stress-induced degradation in degenerative cognitive pathologies.